We are live on ! Find out more
CIM

Contravisory Investment Management Portfolio holdings

AUM $566M
1-Year Est. Return 42.93%
This Fund
S&P 500
This Quarter Est. Return
+13.37%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$322M
AUM Growth
+$28.8M
Cap. Flow
-$2.72M
Cap. Flow %
-0.84%
Top 10 Hldgs %
28.37%
Holding
285
New
38
Increased
61
Reduced
112
Closed
38

Top Buys

Rank Stock Value
1
ADSK icon
Autodesk
ADSK
+$5.66M
2
CGNX icon
Cognex
CGNX
+$5.61M
3
TREX icon
Trex
TREX
+$5.37M
4
UNP icon
Union Pacific
UNP
+$5.15M
5
ROK icon
Rockwell Automation
ROK
+$5.09M

Sector Composition

Rank Sector Weight
1 Technology 26.48%
2 Healthcare 17.99%
3 Financials 12.48%
4 Industrials 10.79%
5 Communication Services 8.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NCLH icon
101
Norwegian Cruise Line
NCLH
$8.55B
$340K 0.11%
+13,373
New +$279K
BLK icon
102
Blackrock
BLK
$175B
$338K 0.1%
468
-13
-3% -$8.62K
CHTR icon
103
Charter Communications
CHTR
$18.1B
$338K 0.1%
511
-1
-0.2% -$637
LRCX icon
104
Lam Research
LRCX
$386B
$338K 0.1%
7,160
-860
-11% -$36.2K
TPR icon
105
Tapestry
TPR
$32.5B
$336K 0.1%
+10,813
New +$274K
WBD icon
106
Warner Bros
WBD
$67.9B
$333K 0.1%
+11,061
New +$271K
CHRW icon
107
C.H. Robinson
CHRW
$17.4B
$330K 0.1%
3,513
-413
-11% -$39.4K
CTSH icon
108
Cognizant
CTSH
$26.3B
$325K 0.1%
3,969
-478
-11% -$36.4K
XLE icon
109
State Street Energy Select Sector SPDR ETF
XLE
$39.1B
$323K 0.1%
17,044
-3,828
-18% -$66K
A icon
110
Agilent Technologies
A
$41.9B
$322K 0.1%
2,721
-328
-11% -$36.3K
ISRG icon
111
Intuitive Surgical
ISRG
$138B
$322K 0.1%
+1,182
New +$293K
ROL icon
112
Rollins
ROL
$18B
$322K 0.1%
8,239
-886
-10% -$34.3K
HZNP
113
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$317K 0.1%
4,330
-294
-6% -$21.9K
RMD icon
114
ResMed
RMD
$31.7B
$316K 0.1%
1,488
-182
-11% -$36.3K
MA icon
115
Mastercard
MA
$491B
$314K 0.1%
880
-100
-10% -$33.3K
HBI
116
DELISTED
Hanesbrands
HBI
$312K 0.1%
21,410
-1,742
-8% -$26.3K
UA icon
117
Under Armour Class C
UA
$2.35B
$311K 0.1%
+20,924
New +$280K
CAG icon
118
Conagra Brands
CAG
$7.12B
$310K 0.1%
8,560
-1,095
-11% -$39.7K
DHR icon
119
Danaher
DHR
$145B
$305K 0.09%
1,546
+25
+2% +$5.01K
TFC icon
120
Truist Financial
TFC
$63.4B
$302K 0.09%
+6,302
New +$285K
ENZL icon
121
iShares MSCI New Zealand ETF
ENZL
$83.2M
$301K 0.09%
4,416
+103
+2% +$6.58K
NOW icon
122
ServiceNow
NOW
$132B
$299K 0.09%
+2,720
New +$283K
WMT icon
123
Walmart Inc
WMT
$890B
$298K 0.09%
6,207
+186
+3% +$9.03K
EMN icon
124
Eastman Chemical
EMN
$8.35B
$297K 0.09%
+2,964
New +$275K
GAP
125
The Gap Inc
GAP
$7.65B
$295K 0.09%
14,617
+13,046
+830% +$274K

Similar funds

Contravisory Investment Management's Q4 2020 Portfolio in Review

As of Q4 2020, Contravisory Investment Management held 285 positions worth $322M, up 9.8% from $293M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Contravisory Investment Management's Q4 2020 filing shows 38 new, 61 increased, 112 reduced and 38 closed positions. Its largest new stake was Cognex: 77,192 shares worth $6.2M. The largest sale was AbbVie, an estimated $6.39M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • Contravisory Investment Management's largest Q4 2020 buy was Cognex: 77,192 shares worth $6.2M.
  • Contravisory Investment Management added most to Autodesk in Q4 2020, an estimated $5.66M increase.
  • Contravisory Investment Management's biggest Q4 2020 reduction was AbbVie, cutting an estimated $6.39M.
  • Contravisory Investment Management fully exited Kimberly-Clark in Q4 2020, selling an estimated $6.15M.
  • Contravisory Investment Management's ten largest holdings make up 28% of its $322M portfolio in Q4 2020.
  • Contravisory Investment Management opened 38 new positions and closed 38 in Q4 2020.
  • Contravisory Investment Management's portfolio value rose 9.8% quarter-over-quarter to $322M.

Based on Contravisory Investment Management's 13F filing for Q4 2020, filed 13 Jan 2021.